A cohort study including subjects with T2DM using insulin, either in combination with oral glucose-lowering drugs or exclusively, by Losada-Grande et al. [47] showed an increased adjusted subhazard ratio for major fractures (HR 1.38; 95% CI 1.06–1.80). The gene discussed is INS; the disease is type 2 diabetes mellitus.